Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 05, 2021

SELL
$68.67 - $84.02 $15,519 - $18,988
-226 Closed
0 $0
Q2 2021

Jul 09, 2021

SELL
$79.87 - $87.53 $1,916 - $2,100
-24 Reduced 9.6%
226 $19,000
Q1 2020

Apr 22, 2020

SELL
$63.18 - $85.97 $3,790 - $5,158
-60 Reduced 19.35%
250 $18,000
Q4 2019

Jan 22, 2020

BUY
$73.04 - $95.72 $22,642 - $29,673
310 New
310 $27,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Savior LLC Portfolio

Follow Savior LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Savior LLC, based on Form 13F filings with the SEC.

News

Stay updated on Savior LLC with notifications on news.